Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles up 2% after Trump rejects return to Iran ceasefire deal terms
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Revolution Medicines prices RASONQUE at $39,800 per month
Kestra Medical Technologies, Ltd. (KMTS) Misses Q4 EPS by 7c
December 11, 2025 4:02 PM ESTKestra Medical Technologies, Ltd. (NASDAQ: KMTS) reported Q4 EPS of ($0.64), $0.07 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $22.6 million, versus $21 million estimate.
For earnings history and earnings-related data on Kestra Medical Technologies, Ltd. (KMTS) click here.
... More